Clinical Trials · NCT06020456
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Groupe Maladies hémorragiques de Bretagne
- Enrollment
- 361
- Start date
- Jan 2022
- Locations
- 12 sites, France
- Primary endpoint
- Comparison of the post-DDAVP FVIII peak in patients of the group "Null variants" vs "No Null variants"